Noted Chinese virologist Zhang Yongzhen faced relocation issues after significant contributions in sharing SARS-CoV-2 genome, raising concerns about his treatment and research output.
Vaccine scientist Anna Durbin highlights the importance of using challenge strains that are more representative of current community-circulating variants to enhance research efficacy.
[
add
]
[
|
|
...
]